Revance Therapeutics, Inc. (RVNC)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 3.6100 |
| Open | 3.7200 |
| Bid | 3.7800 x 400 |
| Ask | 3.8100 x 900 |
| Day's Range | 3.6500 - 4.0575 |
| 52 Week Range | 3.2100 - 37.9800 |
| Volume | |
| Avg. Volume | 1,866,303 |
| Market Cap | 395.5M |
| Beta (5Y Monthly) | 1.09 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
NASHVILLE, Tenn., April 12, 2024--Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
- Business Wire
Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NASHVILLE, Tenn., March 27, 2024--Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Business Wire
Revance Announces Pricing of $100.0 Million Public Offering of Common Stock
NASHVILLE, Tenn., March 04, 2024--Revance Announces Pricing of $100 Million Public Offering of Common Stock
© 2024 Yahoo. All rights reserved.